AMPK agonism optimizes the in vivo activation and antileukemic efficacy of chimeric antigen receptor T cells.

J Immunother Cancer · 2025 · PMC12719903 · PMID 41423271

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a strong trendno p-value reported

There was also a 23% increase in CD98 median fluorescence intensity (MFI) in CD4+CAR T cells ( online supplemental figure 10B ), with a strong trend towards enhanced CD25 MFI staining ( online supplemental figure 10C ).

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.